RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer.

MLA

Lau, Quek Choon, et al. “RUNX3 Is Frequently Inactivated by Dual Mechanisms of Protein Mislocalization and Promoter Hypermethylation in Breast Cancer.” Cancer Research, vol. 66, no. 13, July 2006, pp. 6512–20. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-06-0369.

APA

Lau, Q. C., Raja, E., Salto-Tellez, M., Liu, Q., Ito, K., Inoue, M., Putti, T. C., Loh, M., Ko, T. K., Huang, C., Bhalla, K. N., Zhu, T., Ito, Y., & Sukumar, S. (2006). RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Research, 66(13), 6512–6520. https://doi.org/10.1158/0008-5472.CAN-06-0369

Chicago

Lau, Quek Choon, Erna Raja, Manuel Salto-Tellez, Qiang Liu, Kosei Ito, Masafumi Inoue, Thomas Choudary Putti, et al. 2006. “RUNX3 Is Frequently Inactivated by Dual Mechanisms of Protein Mislocalization and Promoter Hypermethylation in Breast Cancer.” Cancer Research 66 (13): 6512–20. doi:10.1158/0008-5472.CAN-06-0369.